Plunkett Research Online: Matinas BioPharma Hldgs Inc

MATINAS BIOPHARMA HLDGS INC (MTNB:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphoteri.....



Matinas BioPharma Hldgs Inc
Ticker: MTNB
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 908 443-1860
Fax:
Address: 1545 Route 206 South
Suite 302
Bedminster, NJ 07921 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Roelof RongenCEO/Co-Founder/Director
Gary GaglioneCFO/Chief Accounting Officer/Vice President, Divisional
See More
Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphoteri.....See More See More

Auditor: EisnerAmper LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: